Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Connolly
Dual Inhibition of Both the Epidermal Growth Factor Receptor and erbB2 Effectively Inhibits the Promotion of Skin Tumors During Two-Stage Carcinogenesis
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Related publications
Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors
Clinical Cancer Research
Cancer Research
Oncology
Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization
Molecular Cancer Therapeutics
Cancer Research
Oncology
Quantitation of the Effect of ErbB2 on Epidermal Growth Factor Receptor Binding and Dimerization
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Activation of the Epidermal Growth Factor Receptor Promotes Lymphangiogenesis in the Skin
Journal of Dermatological Science
Dermatology
Biochemistry
Molecular Biology
Epidermal Growth Factor Receptor Inhibition Strategies in Oncology
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Dual Epidermal Growth Factor Inhibition and Multi Targeted Epigenetic Therapy (MTET)
Journal of Cancer Therapy
Clinical Significance of the Mutant Epidermal Growth Factor Receptor "ΔEGFR" in Astrocytic Tumors
Japanese Journal of Neurosurgery
Surgery
Neurology
Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Epidermal Growth Factor Receptor Inhibition in Lung Cancer: The Evolving Role of Individualized Therapy
Cancer and Metastasis Reviews
Cancer Research
Oncology
